SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-065237
Filing Date
2024-08-05
Accepted
2024-08-05 17:14:07
Documents
13
Period of Report
2024-08-05
Items
Item 4.01: Changes in Registrant's Certifying Accountant

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210631-8k_bioessence.htm   iXBRL 8-K 24637
  Complete submission text file 0001213900-24-065237.txt   194447

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bioe-20240805.xsd EX-101.SCH 3033
3 XBRL LABEL FILE bioe-20240805_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bioe-20240805_pre.xml EX-101.PRE 22371
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0210631-8k_bioessence_htm.xml XML 3446
Mailing Address 12 CHRYSLER UNIT B IRVINE CA 92618
Business Address 12 CHRYSLER UNIT B IRVINE CA 92618 949-706-9966
Bio Essence Corp (Filer) CIK: 0001723059 (see all company filings)

IRS No.: 943349551 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56263 | Film No.: 241176005
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)